Fludarabine (APP Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the Fludarabine drug offered from APP Pharmaceuticals, LLC. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | APP Pharmaceuticals, LLC |
| NON-PROPRIETARY NAME: | FLUDARABINE PHOSPHATE |
| SUBSTANCE NAME: | FLUDARABINE PHOSPHATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2009-12-11 |
| END MARKETING DATE: | 0000-00-00 |
Fludarabine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Fludarabine from APP Pharmaceuticals, LLC |
| LABELER NAME: | APP Pharmaceuticals, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/mL) |
| START MARKETING DATE: | 2009-12-11 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-196_f1ffd18c-9f6b-4479-94b9-6890bc730ecc |
| PRODUCT NDC: | 63323-196 |
| APPLICATION NUMBER: | ANDA078544 |
Other FLUDARABINE PHOSPHATE Pharmaceutical Manufacturers / Labelers:
